Complications in Hypertension and Obesity

• Conditions: Metabolic Syndrome; Hyperglycemia; Obesity; Dyslipidemia; Hypertension

• Registration Number: NCT00552292
• Lead Sponsor: Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

Brief Summary

The study in aimed to investigate epidemiology of risk factors in Russian Federation its prognostic value aimed on acceptance of national specific definition of metabolic syndrome and guidelines for its management.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2007-10-31
• Study First Submitted QC: 2007-10-31
• Study First Posted: 2007-11-01
• Study Start: 2007-12
• Status Verified: 2016-12
• Last Update Submitted: 2016-12-05
• Last Update Posted: 2016-12-06
• Primary Completion: 2017-05
• Study Completion: 2017-05

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30000

Inclusion Criteria

• Age older 18 years
• Signed informed consent
• Blood pressure more than 130 and/or 85 mm Hg
• Waist circumference more than 80 sm in females and 94 in males and/or BMI more than 25 kg/m2
• Dyslipidemia (elevated TG and/or decreased level of HDLP or therapy for high triglyceride level)
• Fasting glucose more than 5,6 mmol/l

Exclusion Criteria

• Associated clinical conditions (stroke, TIA, MI, heart failure, renal disease, diabetes mellitus)
• Severe concomitant diseases affecting outcome

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
cardiovascular complications	2007-2017

Secondary Outcome Measures

Name	Time	Method
diabetes mellitus	2007-2017

Trial Locations

Locations (1)

Almazov Federal Center of Heart, Blood and Endocrinology; 🇷🇺 St.Petersburg, Russian Federation